Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP651484.RAzB9v89lGKtb46veIXS4tRONDlQAdZgg7jHNjoU75MHw130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651484.RAzB9v89lGKtb46veIXS4tRONDlQAdZgg7jHNjoU75MHw130_provenance.
• NP496311.RANKbfZg4HnPbhHI9ZTmORXC0ygLfwriqZ7Q6Z35Jr80c130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496311.RANKbfZg4HnPbhHI9ZTmORXC0ygLfwriqZ7Q6Z35Jr80c130_provenance.
• NP664279.RAMgDybL5t4zeHYM8DsEDYZji9Sbf2_Q_JMhocLUKykRw130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664279.RAMgDybL5t4zeHYM8DsEDYZji9Sbf2_Q_JMhocLUKykRw130_provenance.
• NP969965.RAtbPkReXEchev4GfP8WPYXoiINadnI6MgBXT0rhxO-to130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969965.RAtbPkReXEchev4GfP8WPYXoiINadnI6MgBXT0rhxO-to130_provenance.
• NP476318.RAfKPIUcRZxZwueMlwkmGOD0WbzPStrwHw4S1cm8y7v8U130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476318.RAfKPIUcRZxZwueMlwkmGOD0WbzPStrwHw4S1cm8y7v8U130_provenance.
• NP476321.RAeS98fdb8azx5XO27QYJrVD4KfTeIzxedwPvfyd7PrC4130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476321.RAeS98fdb8azx5XO27QYJrVD4KfTeIzxedwPvfyd7PrC4130_provenance.
• NP455947.RAmPy4hEvtjytZ7dVBPsGq0lk5TGHuxxdyFeRVtzEFeX0130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455947.RAmPy4hEvtjytZ7dVBPsGq0lk5TGHuxxdyFeRVtzEFeX0130_provenance.
• NP456004.RAprwsj3S0udWXLsJ6svXt1juljwMcYFOtbO8XzZO6nVw130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456004.RAprwsj3S0udWXLsJ6svXt1juljwMcYFOtbO8XzZO6nVw130_provenance.
• NP970483.RAjxWkZJyeuTU7RfeBe2r5XqgcBYVvsw26lBDd3h4zB2U130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP970483.RAjxWkZJyeuTU7RfeBe2r5XqgcBYVvsw26lBDd3h4zB2U130_provenance.
• NP476324.RAp7BHKHBznW5bG4Tg39xdMTnvrc-cUStUh-AZojKtOXU130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476324.RAp7BHKHBznW5bG4Tg39xdMTnvrc-cUStUh-AZojKtOXU130_provenance.
• NP911948.RAOvOzquZcjM0yabnnrsN55801hVzV1G-nrNGbZ2LHT8I130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911948.RAOvOzquZcjM0yabnnrsN55801hVzV1G-nrNGbZ2LHT8I130_provenance.
• NP970456.RAMYXGBtDVfI64HFmcnxPfzRlp0vC6NeKWsuYar76TQ6M130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP970456.RAMYXGBtDVfI64HFmcnxPfzRlp0vC6NeKWsuYar76TQ6M130_provenance.
• NP455124.RAKAVpNxsjYACG0K3l0ox0RnSSpZh5mwOsna5ZmPPRNTc130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455124.RAKAVpNxsjYACG0K3l0ox0RnSSpZh5mwOsna5ZmPPRNTc130_provenance.
• NP476319.RAEExiTFux4eG2uI5CfPB8wCS1Q8SlwgwyPAhJexhkzbs130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476319.RAEExiTFux4eG2uI5CfPB8wCS1Q8SlwgwyPAhJexhkzbs130_provenance.
• NP476325.RAKg3IUmlK6fOHa4sDCwhURP0lOy4gzqTX0lDHSmldAj8130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476325.RAKg3IUmlK6fOHa4sDCwhURP0lOy4gzqTX0lDHSmldAj8130_provenance.
• NP476326.RAzcCWokqORZW-f2gnZpRzBsxOfbM6_nL681A_CWpSV5c130_assertion description "[The analysis of the interaction between H. pylori infection and HLA risk genotypes of CW*03 or DRB1*01 revealed that the effect of CW*03 and DRB1*01 genotypes on gastric cancer risk was manifested stronger in H. pylori-positive individuals (OR=5.30, 95% CI=1.73-16.29, P=0.004 and OR=13.38, 95% CI=2.52-70.98, P=0.002, respectively) than in H. pylori-negative ones (OR=1.25, 95% CI=0.25-6.12, P=0.785 and OR=2.26, 95% CI=0.18-28.88, P=0.531, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476326.RAzcCWokqORZW-f2gnZpRzBsxOfbM6_nL681A_CWpSV5c130_provenance.